Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS) SHH

Currency In CNY

AD

Valuation

Market Cap70.1B
Enterprise Value97.44B
P/E Ratio18.77
PEG Ratio4.62
Price/Sales Ratio1.49
Price/Book Ratio1.3
Enterprise/Revenue2.13
Enterprise/EBITDA13.86

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.08
Operating Margin0.07
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.07

Income Statement

Revenue41.5B
Revenue/Share16.13
Gross Profit19.12B
EBITDA9.99B
Net Income3.37B
Diluted EPS1.27

Balance Sheet

Total Cash16.05B
Total Cash/Share6.08
Total Debt39.54B
Total Debt/Equity0.81
Current Ratio0.9
Book Value Per Share24.25

Price History

52-Week Change-19.5
52-Week High30.09
52-Week Low20.85
Moving Average 50 Days23.04
Moving Average 200 Days24.71

Statistics

Average Volume27.96M
Shares Outstanding2.64B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.39
Trailing Annual Dividend Yield1.62
Payout Ratio0.32
Last Split Factor3:2
Last Split DateJuly 26, 2010
AD